This webinar from the Children’s Tumor Foundation (CTF) was recorded live on September 27, 2023, and includes an important announcement about the results of the INTUITT-NF2 platform clinical trial, and more.
Extraordinary things are underway in the search for effective treatments for NF2-related schwannomatosis and all forms of schwannomatosis. Learn about:
– INTUITT’s innovative platform basket trial design, and the encouraging first results
– CTF’s game-changing investment in the global SYNODOS “dream team” preclinical consortium
– SYNODOS’ groundbreaking screening process that identified promising treatments, including brigatinib Innovative researchers, courageous patients, and bold investors have galvanized NF2-SWN research to a very pivotal moment.
Closed captioning is available by clicking the CC button.
